Posted on

l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor–α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial

URL: https://www.sciencedirect.com/science/article/pii/S0271531717303652

Journal: Nutrition Research

Publication Date: 01/2018

 Summary: l-carnosine lowered fasting glucose, serum levels of triglycerides, AGEs, and tumor necrosis factor–α without changing sRAGE, IL-6, and IL-1β levels in T2D patients.